IFN-γ- and IL-17-producing CD8<sup>+</sup> T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity.

J Immunother Cancer · 2021 · PMC8246372 · PMID 34193567

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the spleen on day 3 following the T-cell transfer, Tc17-1 cells showed a trend for higher frequency among all CD8 + cells compared with Tc1 cells regardless of the additional treatment ( figure 3D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.